Premium
Value of clinical data and vestibular testing in a population of 101 patients with recurrent vestibulopathy
Author(s) -
MartinSanz E.,
Vargas Salamanca E.,
Marqués Cabrero A.,
Esteban J.,
Muerte I.,
SanzFernández R.
Publication year - 2014
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/coa.12287
Subject(s) - medicine , university hospital , otorhinolaryngology , population , family medicine , surgery , environmental health
Meniere’s disease is characterised by episodic vertigo,
fluctuating hearing loss, aural pressure and tinnitus.
Vestibular testing is not even a recommendation in the
AAO-HNS guidelines, one of the most used classifications to
diagnose Meniere’s disease.
Vestibular migraine is a term used to describe a vertigo
syndrome in patients with a history of migraines with or
without aura1 that may affect up to 1% of the general
population.2
In the first year after onset of symptoms, differentiation of
Vestibular migraine from Meniere’s disease is a challenge
because of the overlap in clinical features.3 Some authors
have suggested that Meniere’s disease may coexist with
migraines.4–6
The aim of this study is to evaluate the difficulties in the
diagnosis based on clinical features of a population of
recurrent vestibulopathy congruent with Meniere’s disease
and Vestibular migraine within a period of 2 years.
As vestibular testing is not even a recommendation in the
AAO-HNS guidelines,7 and the role of vestibular tests for the
diagnosis of Vestibular migraine is not well established,8 we
want to analyse the value of vestibular testing in those
patients.2.113 JCR (2014) Q1, 8/43 OtorhinolaryngologyUE